The ultimate objective of this program project application is to understand the pathophysiology of acute and chronic graft-vs.-host disease (GVHD) in humans. To achieve this objective, skin samples and blood specimens from patients will be collected, catalogued, and distributed to the relevant projects for analysis of lymphocytes, chemokines, cytokines, and minor histocompatibility antigen. Individual patient data will he collected for the clinical studies and to provide laboratory observations with clinical correlates. The focus of all projects is to develop targeted strategies that can control GVHD while maintaining graft-vs.-leukemia effects. Integrated data management and specimen tracking are critical for all three projects and extend beyond patient care and clinical laboratory functions. Without the clinical research support provided in the Core it would be impossible to coordinate the proper collection of multiple research samples, assure appropriate tracking of specimens, collect detailed patient-level data, and ensure the highest quality data are available to achieve laboratory and clinical objectives. This core will interact extensively with Dr. Haesook Kim from the Biostatistics Core C who will provide assistance in study design and analysis for the Projects. The purpose of the Data Management and Specimen Tracking Core D is to provide the following services that will be utilized by all three Projects: 1. To help clinical and laboratory investigators identify the necessary patient-level information for their projects, and to design forms, procedures and databases to capture these data. 2. To provide clinical data management for abstraction of individual patient information. 3. To provide a central mechanism for specimen collection, identification and tracking between the three projects. 4. To provide data management support and quality control for clinical data.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL070149-05
Application #
7393107
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
2007-04-01
Project End
2008-03-31
Budget Start
2007-04-01
Budget End
2008-03-31
Support Year
5
Fiscal Year
2007
Total Cost
$269,073
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
02215
Kim, Haesook T; Zhang, Mei-Jie; Woolfrey, Ann E et al. (2016) Donor and recipient sex in allogeneic stem cell transplantation: what really matters. Haematologica 101:1260-1266
Koreth, John; Kim, Haesook T; Lange, Paulina B et al. (2015) A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial. Biol Blood Marrow Transplant 21:1907-13
Gazourian, Lee; Rogers, Angela J; Ibanga, Ruby et al. (2014) Factors associated with bronchiolitis obliterans syndrome and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation. Am J Hematol 89:404-9
Armand, Philippe; Kim, Haesook T; Logan, Brent R et al. (2014) Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation. Blood 123:3664-71
Brown, J R; Kim, H T; Armand, P et al. (2013) Long-term follow-up of reduced-intensity allogeneic stem cell transplantation for chronic lymphocytic leukemia: prognostic model to predict outcome. Leukemia 27:362-9
Gazourian, Lee; Coronata, Anna Maria F; Rogers, Angela J et al. (2013) Airway dilation in bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. Respir Med 107:276-83
Chen, Y-B; McDonough, S; Chen, H et al. (2013) Expression of ýý4ýý7 integrin on memory CD8(+) T cells at the presentation of acute intestinal GVHD. Bone Marrow Transplant 48:598-603
Reddy, Pavan; de Lima, Marcos; Koreth, John (2012) Emerging therapies in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 18:S125-31
Armand, Philippe; Gibson, Christopher J; Cutler, Corey et al. (2012) A disease risk index for patients undergoing allogeneic stem cell transplantation. Blood 120:905-13
Armand, Philippe; Kim, Haesook T; Zhang, Mei-Jie et al. (2012) Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study. Biol Blood Marrow Transplant 18:280-8

Showing the most recent 10 out of 64 publications